Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer
- PMID: 1462098
- DOI: 10.1002/ssu.2980080506
Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer
Abstract
The histogenetic relationships between the subtypes of bladder cancer are not known. Each common pattern (transitional cell carcinoma, adenocarcinoma, and squamous carcinoma) can exist independently, although they may coexist in primary or metastatic bladder cancers, and tumors that are predominantly composed of transitional cell carcinoma may have regions of squamous or glandular differentiation. Morphologically identical tumors exhibit marked variation in their natural history and response to treatment. To study these aspects of the biology of human bladder cancer, a series of cell lines have been established and characterized as xenografts and in tissue culture. These studies have shown a likely common origin for transitional cell carcinoma, adenocarcinoma, and squamous carcinoma of the bladder. Morphologically similar xenografts and cell lines in vitro have shown a broad range of functional heterogeneity, including ultrastructure, tumor marker production, ploidy, cell surface characteristics, and response to chemotherapy. These are useful models of heterogeneity of response to treatment with established and new cytotoxic agents.
Similar articles
-
Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder.Exp Toxicol Pathol. 1998 Sep;50(4-6):341-55. doi: 10.1016/S0940-2993(98)80015-8. Exp Toxicol Pathol. 1998. PMID: 9784006
-
Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder.Prog Clin Biol Res. 1988;260:167-81. Prog Clin Biol Res. 1988. PMID: 3362878
-
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.Urol Oncol. 2009 May-Jun;27(3):284-92. doi: 10.1016/j.urolonc.2008.02.015. Epub 2008 Jun 18. Urol Oncol. 2009. PMID: 18562222
-
Critical review of the models to study the biologic progression of bladder cancer.Semin Surg Oncol. 1992 Sep-Oct;8(5):274-8. doi: 10.1002/ssu.2980080505. Semin Surg Oncol. 1992. PMID: 1462097 Review.
-
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Am J Surg Pathol. 2012. PMID: 22301493 Review.
Cited by
-
High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.Virchows Arch. 2016 Oct;469(4):427-34. doi: 10.1007/s00428-016-2001-2. Epub 2016 Aug 12. Virchows Arch. 2016. PMID: 27520411 Free PMC article.
-
Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.Hum Pathol. 2019 Mar;85:1-9. doi: 10.1016/j.humpath.2018.10.033. Epub 2018 Nov 14. Hum Pathol. 2019. PMID: 30447301 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical